Carl Zeiss Meditec AG (AFX) - Product Pipeline Analysis

Summary

Carl Zeiss Meditec AG (Carl Zeiss Meditec) is a medical equipment company engaged in developing, manufacturing and marketing of medical laser and diagnostic systems, intraocular lenses and consumables for ophthalmic surgery. It is an integrated medical technology company which operates in the fields of ophthalmology, neuro/ENT surgery and surgical ophthalmology. The company’s research and development activities are principally into the development of extreme ultraviolet lithography (EUV). Priority markets include Germany, France, Spain, North America and Japan. Its products are marketed through 40 distribution companies and over 100 agencies worldwide.

Key business strategy includes increased focus on progress in medicine with innovations for ophthalmology and microsurgery to manufacture products and solutions to meet the real needs of clinicians and professionals and thus improve their patients’ quality of life. The company is headquartered in Jena, Germany.

This report is a source for data, analysis and actionable intelligence on the Carl Zeiss Meditec AG portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to buy

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Carl Zeiss Meditec AG - Business Description 5
Key Facts 6
Carl Zeiss Meditec AG - Major Products and Services 7
Carl Zeiss Meditec AG Pipeline Products by Equipment Type 9
Carl Zeiss Meditec AG Pipeline Products by Development Stage 11
Carl Zeiss Meditec AG Pipeline Products by Therapy Area 13
Carl Zeiss Meditec AG Pipeline Products by Trial Phase 15
Carl Zeiss Meditec AG Pipeline Products by Milestone Summary 17
ReLEx Femtosecond Laser System 19
ReLEx Femtosecond Laser System Product Status 19
ReLEx Femtosecond Laser System Product Description 19
ReLEx Femtosecond Laser System Product Milestone 19
Trenion 3D HD Video System 21
Trenion 3D HD Video System Product Status 21
Trenion 3D HD Video System Product Description 21
Trenion 3D HD Video System Product Milestone 21
VisuMax Femtosecond Laser System 23
VisuMax Femtosecond Laser System Product Status 23
VisuMax Femtosecond Laser System Product Description 23
VisuMax Femtosecond Laser System Product Milestone 23
VisuMax Femtosecond Laser System Clinical Trial 24
Carl Zeiss Meditec AG - Key Competitors 27
Carl Zeiss Meditec AG - Key Employees 28
Carl Zeiss Meditec AG - Key Employee Biographies 29
Carl Zeiss Meditec AG - Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 33
Carl Zeiss Meditec AG, Recent Developments 33
Nov 16, 2012: Carl Zeiss Introduces New Family Of Cirrus OCT Products At 2012 AAO-APAO Joint Meeting In Chicago 33
Nov 10, 2012: Carl Zeiss Introduces New Family Of OCT Products At 2012 AAO-APAO Joint Meeting In Chicago 33
Nov 08, 2012: ReLEx smile: First 29 cases treated in US Clinical Trial of new Minimally Invasive, All-Femto Laser Vision Correction Method 34
Sep 07, 2012: Carl Zeiss Meditec To Present Trifocal Intraocular Lenses At Joint Congress Of ESCRS And EURETINA 2012 35
Aug 14, 2012: Carl Zeiss Meditec Reports Revenue Of €199m In Q3 Fiscal 2012 35
Jun 21, 2012: Optiscan Accepts First Purchase Order From Carl Zeiss For Neurosurgery Systems 35
May 25, 2012: Carl Zeiss Presents Fluorescence Technology For Intraoperative Analysis Of Blood Flow In Skin And Muscle Tissue Graft Surgery 36
May 15, 2012: Carl Zeiss Meditec Reports Revenue Of €221.5m In Q2 Fiscal 2012 36
Feb 16, 2012: Carl Zeiss Meditec Presents Forum 3.0 Data Management System At WOC 2012 In Abu Dhabi, UAE 37
Feb 14, 2012: Carl Zeiss Meditec Reports Revenue Of €210.3m In Q1 Fiscal 2012 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Carl Zeiss Meditec AG, Key Facts 1
Carl Zeiss Meditec AG Key Pipeline Products by Equipment Type 1
Carl Zeiss Meditec AG Key Pipeline Products by Therapy Area 1
Carl Zeiss Meditec AG Key Pipeline Products by Development Stage 1
Carl Zeiss Meditec AG Key Pipeline Products by Trial Phase 1
Carl Zeiss Meditec AG, Key Facts 6
Carl Zeiss Meditec AG, Major Products and Services 7
Carl Zeiss Meditec AG Number of Pipeline Products by Equipment Type 9
Carl Zeiss Meditec AG Pipeline Products by Equipment Type 10
Carl Zeiss Meditec AG Number of Pipeline Products by Development Stage 11
Carl Zeiss Meditec AG Pipeline Products by Development Stage 12
Carl Zeiss Meditec AG Number of Pipeline Products by Therapy Area 13
Carl Zeiss Meditec AG Pipeline Products by Therapy Area 14
Carl Zeiss Meditec AG Number of Pipeline Products by Trial Phase 15
Carl Zeiss Meditec AG Pipeline Products by Trial Phase 16
Carl Zeiss Meditec AG Number of Pipeline Products By Milestone Summary 17
Carl Zeiss Meditec AG Pipeline Products by Milestone Summary 18
ReLEx Femtosecond Laser System - Product Status 19
ReLEx Femtosecond Laser System - Product Description 19
ReLEx Femtosecond Laser System - Product Milestone 19
Trenion 3D HD Video System - Product Status 21
Trenion 3D HD Video System - Product Description 21
Trenion 3D HD Video System - Product Milestone 21
VisuMax Femtosecond Laser System - Product Status 23
VisuMax Femtosecond Laser System - Product Description 23
VisuMax Femtosecond Laser System - Product Milestone 23
VisuMax Femtosecond Laser System - A Clinical Trial Of The Relex Smile Procedure For The Correction Of Myopia With The Visumax Femtosecond Laser 24
VisuMax Femtosecond Laser System - Use of the Visumax Femtosecond Laser Lenticule Removal Procedure for the Correction of Myopia 25
VisuMax Femtosecond Laser System - A Prospective Study of Femtosecond Laser Intracorneal Lensectomi in Treatment of Moderate to High Myopia 26
Carl Zeiss Meditec AG, Key Employees 28
Carl Zeiss Meditec AG, Key Employee Biographies 29
Carl Zeiss Meditec AG, Other Locations 30
Carl Zeiss Meditec AG, Subsidiaries 31

List of Figures
Carl Zeiss Meditec AG Pipeline Products by Equipment Type 9
Carl Zeiss Meditec AG Pipeline Products by Development Stage 11
Carl Zeiss Meditec AG Pipeline Products by Therapy Area 13
Carl Zeiss Meditec AG Pipeline Products by Trial Phase 15
Carl Zeiss Meditec AG Pipeline Products by Milestone Summary 17